Empowered Funds
ATRA icon

Empowered Funds’s Atara Biotherapeutics ATRA Stock Holding History

Empowered Funds’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$117K Buy
+13,760
New +$125K ﹤0.01% 2392

Other funds holding ATRA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
STALEY CAPITAL ADVISERS
STALEY CAPITAL ADVISERS Pittsburgh, Pennsylvania $2.67B AUM 20.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return

Empowered Funds's ATRA Position: Q3 2026 in Review

Empowered Funds opened a new position in Atara Biotherapeutics (ATRA) in Q3 2026: 13,760 shares worth $117K. The stake represents ﹤0.01% of the portfolio and ranks #2392 among its holdings.

25 funds tracked by Wall St. Rank hold ATRA as of Q3 2026.

  • Empowered Funds held 13,760 shares of Atara Biotherapeutics worth $117K as of Q3 2026.
  • Atara Biotherapeutics was a new Empowered Funds position in Q3 2026.
  • Atara Biotherapeutics made up ﹤0.01% of Empowered Funds's portfolio in Q3 2026, its #2392 holding.
  • 25 funds tracked by Wall St. Rank held Atara Biotherapeutics as of Q3 2026.

Based on Empowered Funds's 13F filing for Q3 2026, filed 13 Nov 2026.